Das Kloster
Mürgstrasse 18
CH-6370 Stans - Switzerland
T +41 (0)840 200 010
F +41 (0)840 200 011
media@mondobiotech.com
Stans, Switzerland
mondoBIOTECH’s research Community successfully contributes to the global fight against Extensively Drug-Resistant Tuberculosis (XDR-TB)
Stans, Switzerland
Stans, Switzerland
mondoBIOTECH holding AG (SIX Swiss Exchange: RARE) is publishing today its unaudited interim financial results for Q3 2009 which will be part of the offering circular which is being published tomorrow, 26 February 2009
Stans, Switzerland
The shareholders of mondoBIOTECH holding AG have unanimously approved two amendments to the Company's articles of incorporation at today's extraordinary shareholders' meeting, one relating to the usage of conditional share capital, and the other required due to the entry into force of the new Intermediated Security Act
Stans, Switzerland
Stans, Switzerland
mondoBIOTECH holding AG (SIX: RARE), the Swiss biotech company finding therapies for rare diseases announced today a global top ranking position in patent inventions for the year 2009
- Mondobiotech
- Fast fact
- Overview
- Milestones
- Board of Directors
- Management
- Location
- Products
- Product Overview
- Types of products
- Pipeline
- Rare Diseases
- About Rare Diseases
- Patient and Families
- Rare Diseases List
- Media Archive
- Investor
- Financial Information
- Key Information
- Corporate Governance
- Appointments
- Partnership
- Pipeline
- Science
- Pipeline
- Product Overview
- Research Vision